{"id":"W2113708580","doi":"10.1093/annonc/mdr519","title":"Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trial","year":2011,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital du Saint-Sacrement; Dalhousie University","funders":"Merck","keywords":"Medicine; Trastuzumab; Cardiotoxicity; Ejection fraction; Internal medicine; Breast cancer; Regimen; Doxorubicin; Cyclophosphamide; Anthracycline; Metastatic breast cancer; Heart failure; Cardiology; Cancer; Chemotherapy; Gastroenterology; Urology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001921921,0.002138858,0.002434833,0.0003532755,0.0004241729,0.001134641,0.0008284654,0.001739906,0.004246119],"category_scores_gemma":[0.001699166,0.0007450049,0.001559945,0.0004706988,0.001763815,0.001304363,0.0005303672,0.003729942,0.0007964077],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001107549,"about_ca_system_score_gemma":0.001315944,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007052026,"about_ca_topic_score_gemma":0.001297411,"domain_scores_codex":[0.9993103,0.0003214456,0.00003408159,0.0001638633,0.00004632683,0.0001240441],"domain_scores_gemma":[0.9989368,0.0002639713,0.0002506524,0.000120959,0.00004774801,0.0003797642],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9722292,0.008657466,0.001090269,0.000222058,0.0009482453,0.00003843281,0.00005310428,0.0004733713,0.003925878,0.0001126739,0.0004066424,0.01184254],"study_design_scores_gemma":[0.9101759,0.08608118,0.00166055,0.0000181349,0.0005550167,0.00003495593,0.00001941392,0.0003513931,0.0005098857,0.0001545973,0.0004260454,0.00001303341],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943076,0.001588538,0.0005529588,0.0004395623,0.0001862825,0.001536834,0.0003322437,0.00004741035,0.001008588],"genre_scores_gemma":[0.9921496,0.001461543,0.001109714,0.0006854401,0.0002965145,0.001790594,0.000762067,0.00002177336,0.001722786],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004246119,"threshold_uncertainty_score":0.01420468,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08758399274204345,"score_gpt":0.3688849666775735,"score_spread":0.28130097393553,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}